drugset / Trial / NCT04241965

A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

NCT04241965 ↗

Non-randomizedSequentialSingle-blindTreatment

Summary

Despite availability of several antiepileptic drugs (AEDs), in one-third of patients, epilepsy remains uncontrolled with AEDs. There is a need to develop new approaches to improve the existing medications to relieve patients' epilepsy, and OPC-214870 is being studied for this purpose.

Timeline

Start
2020-02-18
Primary completion
2021-10-11
Completion
2021-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject OPC-214870 Unknown 400 mg Oral

Indications